AmerisourceBergen Corporation has signed a three year pharma deals agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis.
This pharma deals supply agreement is effective October 1, 2012.
The contract is expected to contribute approximately 23 percent of the Company’s revenues, and about 3 percent of its earnings per share.
For further deal information visit Current Agreements (subscription required)
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity